Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber's Hereditary Optic Neuropathy.

International journal of molecular sciences·2023

Same author

The Inflammasome-Dependent Dysfunction and Death of Retinal Ganglion Cells after Repetitive Intraocular Pressure Spikes.

Cells·2023

Same author

Natural History of Glaucoma Progression in the DBA/2J Model: Early Contribution of Müller Cell Gliosis.

Cells·2023

Same author

Using Noninvasive Electrophysiology to Determine Time Windows of Neuroprotection in Optic Neuropathies.

International journal of molecular sciences·2022

Same author

Retinal and cortical visual acuity in a common inbred albino mouse.

PloS one·2021

Same author

Nicotinamide-Rich Diet in DBA/2J Mice Preserves Retinal Ganglion Cell Metabolic Function as Assessed by PERG Adaptation to Flicker.

Nutrients·2020

Search research articles

Related Experiment Video

Updated: Oct 31, 2025

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies

Published on: July 28, 2023

Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies.

Vittorio Porciatti¹, Tsung-Han Chou¹

¹Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

|July 2, 2021

Summary

This study introduces a state-transition model to track retinal ganglion cell (RGC) dysfunction, a key indicator in optic neuropathies. The model uses pattern electroretinograms (PERGs) to identify and potentially reverse RGC damage before cell death occurs.

Keywords:

glaucoma optic neuropathy pattern electroretinogram retinal ganglion cell function

More Related Videos

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

Published on: April 25, 2011

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System

Published on: May 12, 2011

Related Experiment Videos

Last Updated: Oct 31, 2025

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies

Published on: July 28, 2023

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

Published on: April 25, 2011

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System

Published on: May 12, 2011

Area of Science:

Ophthalmology
Neuroscience
Computational Biology

Background:

Cellular dysfunction precedes cell death in optic neuropathies like glaucoma.
Assessing retinal ganglion cell (RGC) function is crucial for evaluating neuroprotective strategies.
Pattern electroretinograms (PERGs) offer a non-invasive method to measure RGC function in humans and animal models.

Purpose of the Study:

To present a conceptual state-transition model for understanding RGC dysfunction progression.
To provide mathematical frameworks for analyzing RGC dysfunction dynamics.
To enable hypothesis testing and fitting of experimental PERG data for optic neuropathies.

Main Methods:

Development of a state-transition model inspired by disease management.
Formulation of mathematical equations to describe RGC state transitions.
Utilizing PERG dynamics under physiological stimuli to assess RGC function and reversibility.

Main Results:

The model identifies progressive and potentially reversible stages of RGC dysfunction.
Mathematical parameters allow for the modification of transition dynamics and severity.
PERG analysis differentiates phenotypic responses and assesses treatment efficacy.

Conclusions:

The state-transition model offers a novel framework for studying RGC dysfunction in optic neuropathies.
This approach facilitates the assessment of neuroprotective interventions and drug treatments.
PERG-based modeling can reveal insights into RGC susceptibility and recovery mechanisms.